BCRX — BioCryst Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for BioCryst Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	300	508	424	389	321
Net Total Accounts Receivable
Net Total Receivables	8.65	29.4	50.6	57	79.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	324	566	517	496	422
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.9	15.2	15.4	20.9	31.8
Long Term Investments
Other Long Term Assets
Total Assets	335	588	550	517	490
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	106	104	106	150	160
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	354	695	845	972	966
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-19.3	-107	-295	-456	-476
Total Liabilities & Shareholders' Equity	335	588	550	517	490
Total Common Shares Outstanding